Beta Testing Agreement Terms & Conditions
Payment; Fees. Options MD reserves the right to charge fees for use and access to the Beta Products or may provide the Beta Products for no charge. Options MD reserves the right to start charging or revise fee amounts at any time, at its sole discretion, under this Agreement or after the Beta Products are made widely available and incorporated into a Options MD service.
Limited Use Rights. For the term of the Agreement, Options MD grants to Beta Customer a limited, non-transferable, non-exclusive, revocable right to access and use the Beta Product(s) in connection with an Existing Account to test its functionality and provide Feedback to Options MD. Options MD hosts and retains physical control over the Beta Product(s) and only makes the Beta Product(s) available for access and use by Beta Customer over the Internet through a Web-browser or mobile device. Nothing in this Agreement obligates Options MD to deliver or make available any copies of computer programs or code from the Beta Product(s) to Customer, whether in object code or source code form. Options MD reserves the right, in its sole discretion, to revoke access and use of the Beta Products at any time. Further, Options MD reserves the right to enter (“assume into”) the Existing Account as needed to (i) monitor or measure use of the Beta Product(s); (ii) validate certain features or functionality of the Beta Product(s); and (iii) to provide services or support necessary to maintain the Beta Product(s).
Use Restrictions. Customer may not rent, lease, distribute, or resell the Beta Product(s), or use the Beta Product(s) as the basis for developing a competitive solution (or contract with a third party to do so), or remove or alter any of the logos, trademark, patent or copyright notices, confidentiality or proprietary legends or other notices or markings that are on or in the Beta Product(s).
Feedback. Upon reasonable request by Options MD, Beta Customer agrees to provide suggestions, enhancement requests, and recommendations (individually and collectively, “Feedback”) regarding the Beta Product(s). Feedback shall include informing Options MD about the performance, ease of use, features that may be missing, and any bugs encountered during the use of the Beta Product(s). Options MD may contact Beta Customer and Beta Customer agrees to make available a reasonable amount of time to discuss the Beta Product(s) with Options MD if so requested. Options MD may without restriction or fee use, modify and incorporate this Feedback into the Beta Product(s) and other Options MD products and/or services without any restriction and without any payment.
Intellectual Property. The parties acknowledge that this Agreement does not transfer any right, title or interest in any intellectual property right to the other. Options MD maintains all rights, title and interest in and to all its patents, inventions, copyrights, trademarks, domain names, trade secrets, know-how and any other intellectual property and/or proprietary rights (collectively, “Intellectual Property Rights”). The limited rights granted to Customer to access and use the Beta Product(s) under this Agreement do not convey any additional rights in the Beta Product(s), or in or to any Intellectual Property Rights associated therewith. Subject only to the limited rights to access and use the Beta Product(s) as expressly provided herein, all rights, title and interest in and to the Beta Product(s) and all hardware, software and other components of or used to provide the Beta Product(s), including all related Intellectual Property Rights, will remain with and belong exclusively to Options MD.
Term of Agreement and Renewal. This Agreement shall commence upon the Beta Testing Start Date with first use of Beta Products and shall expire on the Beta Testing End Date (the “Initial Term”). Upon expiration, this Agreement shall automatically renew for subsequent one (1) month periods until terminated by either party (each a “Renewal Term” and, collectively with the Initial Term, the “Term”).
Termination and Expiration. Either party may terminate this Agreement at any time, for any or no reason, and at either party’s convenience by providing written notice to the other. Upon termination of this Agreement, Customer will notify its Users that their access to the Beta Product(s) has terminated, and Options MD may withhold, remove or discard any content, data, or other information that Customer’s Users post or upload into Options MD’s system while using the Beta Product(s). Following termination or expiration of this Agreement, Options MD is not obligated to store, maintain or provide a copy of any content, data or other information that Customer or its Users made available or provided when using the Beta Product(s). If not earlier terminated, Customer’s obligations under this Agreement shall terminate upon termination of this Agreement; provided that the foregoing shall not limit Options MD’s rights pursuant to Section 5 as related to any Feedback provided before or after such termination. Sections 2, 5, 6, 11, and 13 to 18, and all obligations thereunder, shall survive any termination of this Agreement.
Suspension of Services. Options MD may immediately suspend Customer or one of its User’s access to and use of the Beta Product(s) if Customer or one of its Users is in breach of Section 9, provided that the suspension will continue only for as long as reasonably necessary for Customer to remedy the breach.
Confidential Information. Customer acknowledges and agrees that participation in the Beta testing under this Agreement will result in Options MD disclosing certain confidential, proprietary and/or trade secret information related to the Beta Products and/or Options MD (the “Confidential Information”). Such Confidential Information includes, without limitation, the features, functionality and existence of the Beta Product(s), and any know how, trade secrets, computer programs, source code, flowcharts, diagrams, manuals, schematics, development tools, specifications, design documents, marketing information, financial information, business plans or reports made available to Customer. Customer agrees that it will not, without the express prior written consent of Options MD, disclose any Confidential Information or any part thereof to any third party, except to the extent that such Confidential Information (a) is or becomes generally available to the public through any means other than as a result of any act or omission by Customer; (b) is rightfully received by Customer from a third party that is not subject to any obligation of confidentiality with respect thereto and without limitation as to its use; or (c) is independently developed by Customer without any reliance on any Confidential Information. At the termination of this Agreement or at any time by request of Options MD, Customer will return all Confidential Information in its possession to Options MD and further agrees that it will not duplicate, translate, modify, copy, print, disassemble, decompile or otherwise tamper with the Beta Product(s) or any Confidential Information.
Third Party Tool Integrations. If applicable, one or more Beta Products may integrate with third party services. Beta Customer hereby consents to the sharing of the information in the Beta Products with these third party services and certifies that it has any and all required consents for doing so.
Disclaimer of Warranties. THE BETA PRODUCT(S) ARE PROVIDED “AS IS”. OPTIONS MD MAKES NO REPRESENTATIONS OR WARRANTIES, EXPRESS OR IMPLIED, REGARDING THE BETA PRODUCT(S), INCLUDING ANY REPRESENTATION THAT THE SERVICES THEREUNDER WILL BE UNINTERRUPTED OR ERROR-FREE. TO THE FULLEST EXTENT PERMITTED UNDER APPLICABLE LAW, OPTIONS MD DISCLAIMS ANY IMPLIED OR STATUTORY WARRANTY, INCLUDING ANY IMPLIED WARRANTY OF TITLE, NON-INFRINGEMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE IN RESPECT OF THE BETA PRODUCT(S). FOR THE AVOIDANCE OF DOUBT, ALL BETA PRODUCT(S) ARE PRELEASE, ARE EXPECTED TO CONTAIN DEFECTS WHICH MAY BE MATERIAL, AND ARE NOT EXPECTED TO OPERATE AT THE LEVEL OF PERFORMANCE OR COMPATIBILITY OF A FINAL, GENERALLY AVAILABLE PRODUCT OFFERING. BETA PRODUCT(S) MAY NOT OPERATE ACCURATELY AND MAY BE SUBSTANTIALLY MODIFIED PRIOR TO PUBLIC AVAILABILITY OR WITHDRAWN AT ANY TIME. ACCORDINGLY, ACCESS TO AND USE OF THE BETA PRODUCT(S) IS ENTIRELY AT CUSTOMER’S OWN RISK. IN NO EVENT SHALL OPTIONS MD BE LIABLE FOR ANY DAMAGE WHATSOEVER ARISING OUT OF THE USE OF OR INABILITY TO USE THE BETA PRODUCT(S), EVEN IF OPTIONS MD HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. YOU ARE ADVISED TO SAFEGUARD IMPORTANT DATA, TO USE CAUTION AND NOT TO RELY IN ANY WAY ON THE CORRECT FUNCTIONING OR PERFORMANCE OF ANY BETA PRODUCT.
Indemnity. Customer agrees to indemnify and hold Options MD, its officers, directors and employees harmless from any losses (including attorneys’ fees) that result from any third party claims related to Customer’s (or its Users) access, use or misuse of the Beta Product(s), or any act or omission by Customer or its Users in violation of this Agreement.
Dispute Resolution, Governing Law and Venue. The parties will attempt to resolve any dispute related to this Agreement through good faith, informal negotiation. If initial negotiation does not resolve the dispute, the parties will select a mutually agreed mediator in a mutually agreed location to attempt to resolve the dispute. If mediation fails to resolve the dispute, either party may file an action in a federal court in the Northern District of California only and each party irrevocably submits to the jurisdiction and venue of the applicable courts. The laws of the State of California govern this Agreement. The prevailing party in any litigation may seek to recover its legal fees and costs. Any breach of confidentiality obligations in this Agreement, or any unauthorized use of the services or a party’s intellectual property by the other, may cause irreparable harm. In no event may this agreement be governed by the United Nations convention on contracts for the international sale of goods.
Compliance with Laws and Legal Advice. Each party must comply with all laws, rule or regulations applicable to such party’s activities in relation to this Agreement, including export control laws of the United States which are applicable to the Application and which may prohibit use of the Application in certain sanctioned or embargoed countries. Options MD will not provide Customer with any legal advice regarding compliance with data privacy or other relevant laws, rules or regulations in the jurisdictions in which Customer uses the Beta Product(s) (“Laws”). The parties acknowledge and agree that not all features, functions and capabilities of the Beta Product(s)may be used in all jurisdictions and Customer recognizes that certain features, functions and capabilities may need to be configured differently or not used in certain jurisdictions in order to comply with applicable local Laws, and in certain jurisdictions consents may need to be obtained from individuals submitting data via the Beta Product(s) as to the intended purpose, storage, distribution, access and use of the data submitted (“Local Use Decisions”). Customer is responsible for Local Use Decisions and Options MD disclaims all liability for Local Use Decisions.
Miscellaneous. This Agreement does not create a partnership, agency relationship, or joint venture between the parties. Any assignment of this Agreement by Customer in whole or in part without Options MD’s prior written consent will be null and void, except an assignment to a successor that is not a competitor of Options MD’s made in connection with a merger or sale of all or substantially all of Customer’s assets or stock or to an Affiliate. If this Agreement is translated into a language other than English, the translation is for convenience only, and the English language version will govern. If any provision of this Agreement is unenforceable, that provision will be modified to render it enforceable to the extent possible to affect the parties’ intention and the remaining provisions will not be affected. Failure of Options MD to enforce a right under this Agreement shall not act as a waiver of that right or the ability to later assert that right relative to the particular situation involved. This Agreement includes any schedules and exhibits attached hereto. Such documents encompass the entire agreement between Customer and Options MD with respect to the subject matter hereof and supersede all prior representations, agreements and understandings, written or oral. This Agreement may only be altered, amended or modified by duly executed written instrument. All notices to be provided by Options MD to Customer under this Agreement may be delivered in writing (a) by nationally recognized overnight delivery service (“Courier”) or US mail to the contact mailing address provided by Customer on any form; or (b) electronic mail to the electronic mail address provided for Customer’s Existing Account owner. Customer must give notice to Options MD in writing by Courier or US Mail to the following address: Options MD, Inc., Attn: Legal Department, 8721 Santa Monica Blvd. #147, Los Angeles, CA 90069 USA. All notices shall be deemed to have been given immediately upon delivery by electronic mail, or if otherwise delivered upon receipt or, if earlier, two (2) business days after being deposited in the mail or with a Courier as permitted above. You may not assign this Agreement without the prior written consent of Options MD. Subject to the foregoing, the Agreement shall be binding upon the parties and their respective administrators, successors and assigns.